Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pseudomonas Infections 1Neutropenia 1Gram-Positive Bacterial Infections 1Fever 1

Interventions

pegfilgrastim 13Filgrastim 8Cyclophosphamide 3liposomal amphotericin B 2eflapegrastim 2Peripheral Blood Stem Cell Transplantation 2Mitoxantrone 2Levofloxacin 2Idarubicin 2Fluconazole 2Etoposide 2Docetaxel 2Cytarabine 2Ciprofloxacin 2Cefepime 2Caspofungin 2Amsacrine 2pegylated granulocyte colony-stimulating factor 1ceftobiprole medocaril 1Vancomycin 1Tretinoin 1Thioguanine 1Radiotherapy 1Psychiatric Rehabilitation 1MYL-1401H 1Lithium Carbonate 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Daunorubicin 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neutropenia × ceftobiprole medocaril × Clear all
NCT00529282 2012-08-01

A Study of Ceftobiprole in Patients With Fever and Neutropenia.

Basilea Pharmaceutica

Phase 3 Terminated
2 enrolled 4 charts

Fever, Neutropenia, Pseudomonas Infections, Gram-Positive Bacterial Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡